Antiviral drug Remdesivir has shown positive results in the treatment of COVID-19 patients, US-based pharma company Gilead Sciences has said.
In its third phase of clinical trial, a 5-day dosage of the medicine has reportedly improved the condition of 50 per cent of the patients with many discharged from hospitals in two weeks.
“Certainly, it’s a positive, a very positive event,” US President Donald Trump told reporters on Wednesday in response to a question related to the development of Remdesivir.
However, the drug has not been licensed or approved globally for the treatment of COVID-19 patients.
Meanwhile, a study to determine the efficacy of the medicine for a five-day course as compared to a 10-day treatment regime is underway, the company said.
Remdesivir was found to kill viruses like Ebola, Marburg, MERS and SARS. The medication disables virus RNA (ribonucleic acid) replication.
However, the drug failed the human trial stage for treating the Ebola virus in 2018-19.
Bargarh: A new artist will be selected to play the mythological character King Kansa during…
Mumbai: Suhana Khan will be making her Bollywood debut with ‘King’ along with her superstar…
New Delhi: After Diljit Dosanjh called out the double standards of Telangana government for banning…
New Delhi: Recent actions and counter-actions in the Russia-Ukraine conflict have pushed the world to the…
Balangir: Three persons were arrested and fake IPS officers’ uniforms along with fake identity cards…
Mumbai: Abhishek Bachchan’s highly-anticipated film ‘I Want To Talk’ released in theatres on Friday, and the…
New Delhi: Accused of giving cash to secure votes ahead of election day in Maharashtra,…
Bhubaneswar: Chief Minister Mohan Charan Majhi attended the ‘Odisha State Day Celebrations’ at the 43rd…